The mission of the Duke Division of Hematologic Malignancies and Cellular Therapy is to promote health and improve lives by preventing, diagnosing, and treating blood cancer and other life threatening diseases through integrated, innovative, and holistic patient care, education, and research.

Excellence in Patient Care

Our faculty provide comprehensive, multidisciplinary care for patients with hematologic malignancies at the Duke Cancer Center and the Duke Adult Blood & Marrow Transplant Clinic.

Learn more

Excellence in Research

The Duke Hematologic Malignancies and Cellular Therapy (HMCT) Program is a multidisciplinary basic, translational, and clinical research program whose overall goal is to improve outcomes for patients with hematologic malignancies. 

Learn more

Train with us

The Hematology-Oncology Fellowship program provides clinical and laboratory training in hematology, medical oncology, and bone marrow transplantation.

Learn more

Latest News

News
Monday, December 21, 2020
News
Saturday, October 31, 2020
News
Wednesday, July 1, 2020
News
Monday, May 11, 2020
News
Investing in our people
Monday, April 6, 2020

Upcoming Events

Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

May 21, 2021 - 8:30am
Dr. Carlos deCastro
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

May 28, 2021 - 8:30am
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

June 4, 2021 - 8:30am
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

June 11, 2021 - 8:30am
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

June 18, 2021 - 8:30am
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

June 25, 2021 - 8:30am